Contineum Therapeutics Initiates Patient Dosing in Phase 1b Positron Emission Tomography (PET) Trial of PIPE-791 – Business Wire

Your email address will not be published. Required fields are marked *

Save my name, email, and website in this browser for the next time I comment.